Nova Biomedical Corporation

200 Prospect Street, 02454 Waltham, MA
United States of America

Telephone +1 800 4585813
Fax +1 781 8945915

This company is co-exhibitor of
Messe Düsseldorf North America


Hall map

MEDICA 2016 hall map (Hall 3): stand D45-2

Fairground map

MEDICA 2016 fairground map: Hall 3

Our range of products

Product categories

  • 03  Diagnostics
  • 03.01  Clinical chemistry
  • 03.01.08  Devices and systems for glucose determination units

Our products

Product category: Devices and systems for glucose determination units

Only glucose meters accurate enough to be FDA-cleared for use with ALL patients, including critically ill

ONLY glucose meters cleared by the FDA for use with all patients, in all professional healthcare settings, including critical care • Eliminates interference which cause incorrect glucose readings and misdosed insulin.

ONLY glucose meters that are CLIA-waived for use with all patients including critically ill • Nursing and point-of-care (POC) operators can perform testing with all patients

Accuracy proven in study of 1,698 critically ill patients with over 257 medical conditions
• Improved accuracy results in fewer insulin misdoses and better outcomes for critically ill patients

Excellent correlation to IDMS traceable laboratory methods
• ONLY glucose meter proven to have no known clinical interferences
• Tested over 8,000 medications with no interferences

ONLY glucose measurement technology specifically designed for hospital use
Wireless meter connectivity to LIS/HIS with StatStrip Glucose

In 2014, after an extensive, nearly four-year project conducted at five major university medical centers, Nova Biomedical achieved a major breakthrough in intended use for the StatStrip Glucose Hospital Meter System. In response to Nova’s 510(k) submission (K132121), the U.S. Food and Drug Administration (FDA) cleared StatStrip Glucose for use throughout all professional healthcare settings including critical care. It is the only glucose meter to obtain this clearance.

“This device [StatStrip Glucose] provides an important public health resource for critically ill hospitalized patients, who often have conditions or are taking medications that can cause incorrect blood glucose reading. It is important for manufacturers of glucose meters used in hospitals to design and test their devices for use in all hospitalized patients.”1

On January 27, 2016, the FDA cleared Nova’s StatStrip Xpress2 Glucose Hospital Meter System for use throughout all professional healthcare settings, including critical care. StatStrip Xpress2 Glucose utilizes the same test strip measurement technology as StatStrip Glucose. StatStrip Glucose and StatStrip Xpress2 Glucose are now the only hospital glucose meters to be cleared by the FDA for use with critically ill patients.

More Less

About us

Company details

Nova features the Stat Profile® Prime family of blood gas / critical care analyzers plus StatStrip® and StatSensor® handheld meters for Point-of-Care whole blood glucose, ketones, lactate, hematocrit/hemoglobin and creatinine testing. Nova also provides Nova Max Plus self-test glucose meters and strips.

More Less

Company data

Sales volume

200-499 Mio US $

Export content

max. 50%

Number of employees




Area of business
  • Electromedical equipment / Medical Technology
  • Laboratory Equipment
  • Diagnostics